Investor Presentaiton
Coloplast revenue development by geography and total
59
Europe
Other Developed Markets
15
12
2
4
6
2
4
6
16
21
22
12,916
10,573
10,820
11,261
8
6
11
11
3
6,878
5
5,775
4,380
4,644
4,785
3,187
18/19
19/20
20/21
21/22
YTD 22/23
18/19
19/20
20/21
21/22
YTD 22/23
FY 21/22 and YTD 22/23 reported growth rates include 8%-pts impact from the Atos
Medical acquisition
Emerging Markets
FY 21/22 and YTD 22/23 reported growth rates include respectively 6%-pts and 5%-pts
impact from the Atos Medical acquisition
15
15
12
10
9
8
10
10
3
2,986
3,080
3,380
3,888
2,101
18/19
19/20
20/21
21/22
YTD 22/23
FY 21/22 and YTD 22/23 reported growth rates include 1%-pts impact from the Atos
Medical acquisition
Revenue (DKKm)
Coloplast group
9
4
7
16
14
3
5
6
22,579
17,939
18,544
19,426
12,166
18/19
19/20
20/21
21/22
YTD 22/23
FY 21/22 and YTD 22/23 reported growth rates include 6%-pts impact from the Atos
Medical acquisition
Reported growth (%)
Organic growth (%)
ColoplastView entire presentation